Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

August 31, 2011

Conditions
PsoriasisVascular InflammationCoronary Atherosclerosis
Interventions
BIOLOGICAL

adalimumab

Injection of adalimumab (80 mg followed by 40 mg at week 1 and 40 mg EOW thereafter for 15 weeks)

DEVICE

UVB Phototherapy

This intervention can be applied alone or in combination with topical treatment. It will be performed between Day 0 and Day 112. The investigator is free to introduce or modify the topical and/or UVB regimens at any time after screening.

OTHER

Topical treatment

"This intervention can be applied alone or in combination with UVB phototherapy. It will be performed between Day 0 and Day 112. The investigator is free to introduce or modify the topical and/or UVB regimens at any time after screening. The investigator will prescribe to patients randomized in this arm a select topical product from the list:~Calcipotriol, Calcipotriene, Dovonex, Tazorac, Tazarotene Anthralin, Corticosteroids."

Trial Locations (2)

H1T 1C8

Montreal Heart Institute, Montreal

H2K 4L5

Innovaderm Research Inc, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

Montreal Heart Institute

OTHER

lead

Innovaderm Research Inc.

OTHER